Junran Zhang

11PUBLICATIONS
79CO-AUTHORS
Molecular targetsSolid mechanicsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 28, 2026
Inhibition of Translesion DNA Synthesis Sensitizes BRCA-Deficient Ovarian Cancer to PARP Inhibitors.

|Jun 06, 2026
IQGAP3 bridges matrix stiffness with glioma stem cell maintenance and radioresistance by stabilizing SOX2.

|Jan 28, 2026
SREBP-1 increases glucose uptake to promote tumor resistance to lysosome inhibition.

Yaogang Zhong, Feng Geng, Huali Su

|May 31, 2024
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity.

Chandra Bhushan Prasad, Adrian Oo, Yujie Liu

|Oct 13, 2023
Unlocking Translational Potential: Conditionally Reprogrammed Cells in Advancing Breast Cancer Research.

Danyal Daneshdoust, Mingjue Luo, Zaibo Li

|May 19, 2023
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity.

Chandra Bhushan Prasad, Adrian Oo, Zhaojun Qiu

Pageof 2

Frequent Collaborators

8 joint publications

Qi-En Wang

6 joint publications

Zaibo Li

3 joint publications

Chandra Bhushan Prasad

3 joint publications

Deliang Guo